Substance P receptor antagonist inhibits murine IgM expression in developing schistosome granulomas by blocking the terminal differentiation of intragranuloma B cells-Reference-Cited by-同舟云学术

Substance P receptor antagonist inhibits murine IgM expression in developing schistosome granulomas by blocking the terminal differentiation of intragranuloma B cells

Published:1996-05 Issue:1-2 Volume:66 Page:1-10
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Blum Arthur,Metwali Ahmed,Elliott David,Sandor Matyas,Lynch Richard,Weinstock Joel V.

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference37 articles.

1. Interleukin-6 in biology and medicine;Akira;Adv. Immunol.,1993

2. Substance P selectively activates TNF-α gene expression in murine mast cells;Ansel;J. Immunol.,1993

3. Substance P modulates antigen-induced, IFN-γ production in murine schistosomiasis mansoni;Blum;J. Immunol.,1993

4. Substance P and somatostatin can modulate the amount of IgG2a secreted in response to schistosome egg antigens in murine schistosomiasis mansoni;Blum;J. Immunol.,1993

5. Substance P: a late-acting B lymphocyte differentiation cofactor;Bost;Am. J. Physiol.,1991

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuropeptides for Mucosal Immunity;Mucosal Immunology;2005

2. Treatment with Neurokinin-1 Receptor Antagonist Reduces Severity of Inflammatory Bowel Disease Induced by Cryptosporidium parvum;Clinical and Vaccine Immunology;2002-03

3. Interleukin 12 and antigen independently induce substance P receptor expression in T cells in murine schistosomiasis mansoni;The FASEB Journal;2001-04

4. Interleukin 12 and antigen independently induce substance P receptor expression in T cells in murine schistosomiasis mansoni;The FASEB Journal;2001-04

5. The pathogenesis and modulation of the post-treatment reactive encephalopathy in a mouse model of Human African Trypanosomiasis;Journal of Neuroimmunology;1999-12